Angioplasty Balloons Market Trends

ID: MRFR/HC/8136-HCR

200 Pages

Rahul Gotadki

October 2025

Angioplasty Balloons Market Research Report By Type (Drug-Eluting Balloons, Plain Old Balloons, Scoring Balloons), By Application (Coronary Angioplasty, Peripheral Angioplasty, Renal Angioplasty), By Material (Polymer, Latex, Metal), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Angioplasty Balloons Market

The angioplasty balloons market is experiencing significant growth due to the rising prevalence of cardiovascular diseases worldwide. Conditions such as coronary artery disease, atherosclerosis, and peripheral artery disease contribute to the demand for angioplasty procedures, where balloons are essential tools for restoring blood flow by dilating narrowed or blocked arteries. The angioplasty balloons market is contingent upon the timeless technological advancements. Implantation of drug-coated and drug-eluting balloons relieves this problem by enabling a medication release, thus reducing reoccurring narrowing of arteries. Second, new advances in the balloon material types, shapes and in coatings lead to better efficacy and patient outcomes. The rapidly growing popularity of minimal invasion surgeries is fueling the market’s growth of angioplasty balloons. More and more patients and health care providers choose minimally invasive interventions that cause less bleeding, take only a little of openings; the recovery times are acceptable. Balloons assisted angioplasty serves as a less disruptive in what one would need to do when it comes to treating arterial blockages operatively. One of the key drivers that have established the angioplasty balloons market is the aging population around the world. Cardiovascular complications become more common for elderly people, and angioplasty interventions with a use of balloons to open narrowed blood vessels are most often performed in this age group as there used to manage and treat the age – related arterial conditions. The market for Life sciences 17A diseases being monitored is growing partly because there are more people made aware of the need to monitor cardiovascular health and the importance of early intervention. Patients are coming early to seek medical attention and hence more angioplasty is done with an expectation that it will discourage or cure the patient from further getting ill. Prompt provision of arterial blockages include the angioplasty balloons which are among mechanisms that addresses the issue. The Diabetes figures are steady in the world-wide increasing and resulting in market growth for angioplasty balloons. In diabetic patients, general and specific vascular complications as also: atherosclerosis increase. In case of angioplasty the use of balloon immediately comes into play as one of the crucial interventions that treat arterial narrowing in diabetic patients and enlarge it with an aim to enhance blood flow. Angioplasty procedures show increasing tendency to use drug-coated balloons rather than other methods. These balloons introduce the agents that are therapeutic to the treated vessel, thus reducing a lot of risk that is associated with restenosis. The change towards the application of drug-coated balloons does not indicate an appreciation for angioplasty; instead, it implies an obsession with increasing long-term efficacy and boosting patient outcomes. Global health emergencies including COVID-19 have made the need for optimal cardiovascular health absurd. Angioplasty balloons are crucially important as an instrument to handle acute cardiac conditions and their demand became even more prominent in the contexts of health crises, thus propelling market growth. In developing angioplasty balloons, the manufacturer’s lens has been focused on customization and a patient-centric approach. When selecting what balloon design would work best for a particular patient or coating the exterior of its surface, this makes the procedure much more customized in its nature and provides superior results. This method also falls in line with the greater shift towards personalized medicine in the general medical fraternity. The angioplasty balloons market is marked by collaborations and partnerships between medical device manufacturers, research institutions, and healthcare providers. Collaborative efforts aim to advance balloon technologies, conduct clinical trials, and improve procedural techniques, fostering innovation and progress in the field.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected market valuation of the Angioplasty Balloons Market by 2035?

The projected market valuation of the Angioplasty Balloons Market is expected to reach 5.1 USD Billion by 2035.

What was the overall market valuation of the Angioplasty Balloons Market in 2024?

The overall market valuation of the Angioplasty Balloons Market was 3.38 USD Billion in 2024.

What is the expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035?

The expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035 is 3.81%.

Which segment is projected to have the highest valuation in the Angioplasty Balloons Market by 2035?

The Drug-Eluting Balloons segment is projected to reach a valuation of 2.0 USD Billion by 2035.

What are the key applications of angioplasty balloons in the market?

The key applications include Coronary Angioplasty, Peripheral Angioplasty, and Renal Angioplasty, with Coronary Angioplasty projected to reach 2.45 USD Billion by 2035.

Which materials are predominantly used in the production of angioplasty balloons?

The predominant materials include Polymer, Latex, and Metal, with Polymer expected to reach 2.0 USD Billion by 2035.

What is the expected valuation of the Ambulatory Surgical Centers segment by 2035?

The Ambulatory Surgical Centers segment is expected to reach a valuation of 1.25 USD Billion by 2035.

Who are the leading players in the Angioplasty Balloons Market?

The leading players in the Angioplasty Balloons Market include Boston Scientific, Medtronic, and Abbott Laboratories.

What was the valuation of the Scoring Balloons segment in 2024?

The Scoring Balloons segment was valued at 1.03 USD Billion in 2024.

How does the market for Plain Old Balloons compare to Drug-Eluting Balloons by 2035?

By 2035, the Plain Old Balloons segment is projected to reach 1.5 USD Billion, while Drug-Eluting Balloons is expected to reach 2.0 USD Billion.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Angioplasty Balloons Market Size was estimated at 3.38 USD Billion in 2024. The Angioplasty Balloons industry is projected to grow from 3.509 USD Billion in 2025 to 5.1 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.81 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Angioplasty Balloons Market is poised for growth driven by technological advancements and increasing healthcare investments.

North America remains the largest market for angioplasty balloons, reflecting a robust healthcare infrastructure. Asia-Pacific is emerging as the fastest-growing region, fueled by rising healthcare expenditures and population awareness. Drug-eluting balloons dominate the market, while scoring balloons are witnessing rapid growth due to their innovative designs. Technological advancements and the rising prevalence of cardiovascular diseases are key drivers propelling market expansion.

Angioplasty Balloons Market

CAGR

3.81%

Market Size & Forecast

2024 Market Size	3.38 (USD Billion)
2035 Market Size	5.1 (USD Billion)
CAGR (2025 - 2035)	3.81%
Largest Regional Market Share in 2024	North America

Major Players

Boston Scientific (US), <a href="https://www.medtronic.com/in-en/healthcare-professionals/products.html">Medtronic </a>(US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cordis (US), Terumo Corporation (JP), Asahi Intecc Co., Ltd. (JP), Cook Medical (US), AngioDynamics (US)

Market Trends

The Angioplasty Balloons Market is currently experiencing a notable evolution, driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases. The demand for minimally invasive procedures has surged, as healthcare providers and patients alike seek alternatives to traditional surgical methods. This shift is fostering innovation in balloon designs, materials, and delivery systems, which are becoming more sophisticated and tailored to specific patient needs. Furthermore, the growing awareness of preventive healthcare is prompting more individuals to seek early intervention, thereby expanding the market's reach and potential. In addition, regulatory bodies are playing a crucial role in shaping the landscape of the Angioplasty Balloons Market. Stricter guidelines and quality standards are being implemented to ensure patient safety and efficacy of devices. This regulatory environment, while challenging, is likely to encourage manufacturers to invest in research and development, leading to the introduction of novel products. As the market continues to mature, collaboration between industry stakeholders, including healthcare providers, manufacturers, and regulatory agencies, appears essential for fostering innovation and improving patient outcomes.

Technological Advancements

The Angioplasty Balloons Market is witnessing rapid technological advancements, particularly in balloon design and materials. Innovations such as drug-eluting balloons and bioresorbable materials are enhancing the effectiveness of procedures, potentially leading to better patient outcomes. These developments may also contribute to reduced recovery times and lower complication rates.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases is significantly influencing the Angioplasty Balloons Market. As more individuals are diagnosed with conditions requiring angioplasty, the demand for effective treatment options is likely to rise. This trend underscores the importance of timely interventions and the need for advanced medical devices.

Regulatory Influence

Regulatory bodies are becoming increasingly influential in the Angioplasty Balloons Market. Stricter regulations and quality standards are being established to ensure the safety and efficacy of medical devices. While this may pose challenges for manufacturers, it also encourages innovation and the development of higher-quality products.

Angioplasty Balloons Market Market Drivers

Regulatory Influence on Market Dynamics

Regulatory frameworks play a crucial role in shaping the Angioplasty Balloons Market. Stringent regulations ensure the safety and efficacy of medical devices, including angioplasty balloons. Compliance with these regulations can be a double-edged sword; while they may pose challenges for manufacturers, they also foster innovation and quality improvements. Regulatory bodies are increasingly focusing on post-market surveillance and real-world evidence, which can influence product development and market entry strategies. As companies navigate these regulatory landscapes, the Angioplasty Balloons Market is likely to evolve, with an emphasis on transparency and patient safety. This dynamic environment may lead to the introduction of new products that meet regulatory standards.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases is a primary driver for the Angioplasty Balloons Market. As populations age and lifestyle-related health issues become more prevalent, the demand for effective treatment options rises. Statistics indicate that cardiovascular diseases remain a leading cause of mortality worldwide, prompting healthcare systems to seek innovative solutions. Angioplasty procedures, facilitated by advanced balloon technologies, are becoming a standard treatment for conditions such as coronary artery disease. This growing patient population necessitates a robust supply of angioplasty balloons, thereby propelling market growth. The Angioplasty Balloons Market is thus positioned to expand as healthcare providers respond to this urgent need.

Growing Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a significant driver for the Angioplasty Balloons Market. As countries prioritize healthcare improvements, the establishment of advanced medical facilities and the procurement of cutting-edge medical devices become essential. Increased funding for cardiovascular care, particularly in emerging markets, is expected to enhance access to angioplasty procedures. This trend is supported by government initiatives aimed at reducing the burden of cardiovascular diseases. Consequently, the demand for angioplasty balloons is anticipated to rise, as healthcare providers seek to equip their facilities with the latest technologies. The Angioplasty Balloons Market stands to benefit from this influx of investment, potentially leading to enhanced patient care.

Technological Advancements in Angioplasty Balloons

The Angioplasty Balloons Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as drug-eluting balloons and bioresorbable materials are enhancing the efficacy of angioplasty procedures. These advancements not only improve patient outcomes but also reduce the risk of restenosis, a common complication. The introduction of advanced imaging techniques and minimally invasive procedures is further driving the adoption of angioplasty balloons. According to recent data, the market for drug-eluting balloons is projected to grow significantly, indicating a shift towards more effective treatment options. As healthcare providers increasingly adopt these technologies, the Angioplasty Balloons Market is likely to witness substantial growth in the coming years.

Increasing Awareness and Education on Cardiovascular Health

The growing awareness and education surrounding cardiovascular health are pivotal for the Angioplasty Balloons Market. Public health campaigns and educational initiatives are informing populations about the risks associated with cardiovascular diseases and the importance of early intervention. As individuals become more knowledgeable about treatment options, including angioplasty, the demand for these procedures is likely to increase. Healthcare providers are also focusing on patient education, which can lead to higher rates of diagnosis and treatment. This heightened awareness is expected to drive the adoption of angioplasty balloons, as patients seek effective solutions for their cardiovascular issues. The Angioplasty Balloons Market is thus poised for growth as awareness continues to expand.

Market Segment Insights

By Type: Drug-Eluting Balloons (Largest) vs. Scoring Balloons (Fastest-Growing)

In the Angioplasty Balloons Market, Drug-Eluting Balloons command a significant share due to their ability to deliver medication directly to the affected area, thereby reducing the risk of restenosis. Plain Old Balloons, while being a standard choice, cater to a specific segment of patients who may not require advanced therapy. Scoring Balloons are gradually carving out their niche with their ability to provide enhanced vessel modifications, thus complementing the existing offerings in this market.

Drug-Eluting Balloons (Dominant) vs. Scoring Balloons (Emerging)

Drug-Eluting Balloons hold a dominant position in the <a href="https://www.marketresearchfuture.com/reports/angioplasty-balloons-market-9614">Angioplasty </a>Balloons Market due to their unique design that combines angioplasty with localized drug therapy. This has proven effective in reducing restenosis rates, making them a preferred choice among cardiologists. In contrast, Scoring Balloons are an emerging solution that provides mechanical help to opened vessels and encourage positive remodeling of the arteries. Their growth is driven by increasing procedural volume and the need for innovative technologies that ensure patient safety and efficacy, positioning them as a promising alternative to traditional options.

By Application: Coronary Angioplasty (Largest) vs. Peripheral Angioplasty (Fastest-Growing)

In the Angioplasty Balloons Market, the application segment is prominently dominated by coronary angioplasty. This segment holds the majority market share due to the high prevalence of coronary artery diseases and the increasing number of angioplasty procedures globally. Peripheral angioplasty follows closely, showing significant growth as healthcare providers focus on treating peripheral artery diseases, which have become increasingly recognized and treated in recent years.

Coronary Angioplasty (Dominant) vs. Peripheral Angioplasty (Emerging)

Coronary angioplasty remains the dominant segment in the Angioplasty Balloons Market, primarily because of its established use and effectiveness in treating coronary artery blockages. It is widely favored among healthcare professionals and patients for its proven success rates. On the other hand, peripheral angioplasty is an emerging segment that has gained traction due to the rising incidence of peripheral artery disease (PAD). This segment is expected to witness robust growth driven by advancements in balloon technology and increasing awareness about the treatment options available for chronic limb ischemia. The increasing patient population and the need for minimally invasive procedures further support the expansion of this segment.

By Material: Polymer (Largest) vs. Metal (Fastest-Growing)

In the Angioplasty Balloons Market, the material segment showcases a diverse range of options, with polymers leading the share distribution. Polymeric balloons are favored for their flexibility and compliance, making them ideal for various angioplasty procedures. They account for a significant portion of market usage, offering a superior balance of performance and patient safety. On the other hand, metal balloons, although smaller in market share, are gaining traction due to their robustness and ability to maintain shape under high-pressure conditions, making them suitable for specific clinical applications. The growth trends indicate a pronounced shift towards polymer <a href="https://www.marketresearchfuture.com/reports/orthopedic-biomaterial-market-415">materials</a>, driven by technological advancements and increasing demand for minimally invasive procedures. Furthermore, the market for metal balloons is rapidly expanding as they are recognized for their durability and efficacy in challenging anatomical circumstances. As healthcare providers continue to prioritize patient outcomes, the development of advanced polymer formulations and metal balloon designs is expected to accelerate, shaping the competitive landscape of the Angioplasty Balloons Market.

Polymer (Dominant) vs. Metal (Emerging)

Polymer balloons dominate the Angioplasty Balloons Market due to their excellent performance characteristics, including flexibility, compliance, and safety. These attributes enable them to effectively navigate the vascular system while minimizing the risk of vessel trauma. Their adaptability to various angioplasty techniques makes them the preferred choice among healthcare professionals. In contrast, metal balloons represent an emerging segment, characterized by their strength and ability to withstand high pressures. Although they have a smaller market presence, their unique properties are leading to increased adoption in certain scenarios, particularly where durability is essential. The distinction between these materials is critical, as they cater to different clinical needs and influence procedural outcomes.

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Angioplasty Balloons Market, hospitals represent the largest end-use segment, catering to a significant share of procedures due to their comprehensive facilities and specialized staffing. Ambulatory Surgical Centers (ASCs), although smaller in market share compared to hospitals, are quickly gaining traction, attributed to their efficiency and cost-effectiveness. The growth trends within this segment indicate a strong inclination towards minimally invasive procedures conducted in ASCs, which are seen as a more patient-centric approach. The increasing preference for outpatient services and technological advancements, such as improved balloon designs, are key factors driving the expansion of ASCs in the market.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals continue to dominate the Angioplasty Balloons Market due to their extensive infrastructure, broader range of services, and 24/7 availability of healthcare professionals. They are well-equipped to handle complex cases and offer comprehensive post-procedure care, making them a preferred choice for critical interventions. On the other hand, Ambulatory Surgical Centers are emerging as a popular alternative owing to their focus on outpatient care, lower costs, and increased patient convenience. ASCs leverage advancements in medical technology and a streamlined approach to procedures, which appeals to a growing patient base opting for less invasive surgical options. This shift in preferences is reshaping the landscape of the angioplasty balloons market.

Get more detailed insights about Angioplasty Balloons Market Research Report - Forecast till 2035

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for angioplasty balloons, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on innovation. Regulatory support from agencies like the FDA facilitates rapid product approvals, enhancing market dynamics. The demand for minimally invasive procedures is also on the rise, further propelling market growth. The United States is the leading country in this region, with major players such as Boston Scientific, Medtronic, and Abbott Laboratories dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships among key players. Canada also contributes significantly to the market, focusing on improving healthcare access and patient outcomes, thereby supporting the overall growth of the angioplasty balloon market.

Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for angioplasty balloons, accounting for approximately 30% of the global market share. The region benefits from a robust healthcare system and increasing investments in medical technology. Regulatory frameworks, such as the Medical Device Regulation (MDR), are evolving to ensure patient safety and product efficacy, which in turn drives market growth. The rising incidence of cardiovascular diseases and an aging population further fuel demand for angioplasty procedures. Leading countries in Europe include Germany, France, and the UK, where key players like B. Braun Melsungen AG and Cordis are actively involved. The competitive landscape is marked by innovation and collaboration among manufacturers to enhance product offerings. The presence of advanced research institutions also supports the development of cutting-edge technologies in the angioplasty balloon market.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is witnessing rapid growth in the angioplasty balloons market, driven by increasing healthcare expenditure and a rising prevalence of cardiovascular diseases. The region holds approximately 20% of the global market share, with countries like Japan and China leading the charge. Government initiatives aimed at improving healthcare infrastructure and access to advanced medical technologies are significant growth drivers. The demand for minimally invasive procedures is also on the rise, contributing to market expansion. Japan is a key player in this market, with companies like Terumo Corporation and Asahi Intecc Co., Ltd. leading the way. The competitive landscape is characterized by a mix of local and international players, fostering innovation and collaboration. Additionally, the growing awareness of cardiovascular health among the population is expected to further boost the demand for angioplasty balloons in the region.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging as a potential market for angioplasty balloons, holding approximately 5% of the global market share. The growth is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Governments are focusing on enhancing healthcare infrastructure and access to advanced medical technologies, which are crucial for market development. The demand for angioplasty procedures is expected to rise as awareness of cardiovascular health improves. Leading countries in this region include South Africa and the UAE, where healthcare reforms are paving the way for advanced medical solutions. The competitive landscape is still developing, with opportunities for both local and international players to enter the market. Key players are beginning to explore partnerships and collaborations to expand their reach in this untapped market.

Key Players and Competitive Insights

The Angioplasty Balloons Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Boston Scientific (US) emphasizes the development of advanced balloon technologies, while Medtronic (US) is leveraging its extensive distribution network to penetrate emerging markets. Abbott Laboratories (US) appears to be concentrating on expanding its product portfolio through acquisitions, thereby enhancing its competitive edge in this rapidly evolving sector.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure is moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and innovations, fostering a competitive environment where companies must continuously adapt to maintain their market share.

In August 2025, Boston Scientific (US) announced the launch of its latest drug-coated balloon, which is designed to improve patient outcomes in complex coronary interventions. This strategic move not only reinforces Boston Scientific's commitment to innovation but also positions the company to capture a larger share of the growing market for advanced angioplasty solutions. The introduction of this product is expected to enhance procedural efficiency and patient safety, thereby solidifying the company's reputation as a leader in the field.

In September 2025, Medtronic (US) entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its angioplasty balloon offerings. This collaboration aims to enhance patient engagement and streamline post-procedural care, reflecting a broader trend towards digital health solutions. By incorporating telehealth features, Medtronic (US) is likely to improve patient outcomes and satisfaction, which could translate into increased market share in the competitive landscape.

In July 2025, Abbott Laboratories (US) completed the acquisition of a smaller medical device company specializing in innovative balloon technologies. This acquisition is indicative of Abbott's strategy to bolster its product offerings and expand its technological capabilities. By integrating these new technologies, Abbott Laboratories (US) is poised to enhance its competitive positioning and respond more effectively to the evolving needs of healthcare providers and patients.

As of October 2025, the Angioplasty Balloons Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are becoming increasingly important, as companies seek to leverage complementary strengths to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, supply chain reliability, and enhanced patient outcomes. This shift underscores the necessity for companies to invest in research and development to stay ahead in a market that is rapidly changing.

Key Companies in the Angioplasty Balloons Market market include

Industry Developments

Recent developments in the Angioplasty Balloons Market indicate a significant increase in demand driven by the rise in cardiovascular diseases globally.

Companies like Medtronic Cardiovascular and Boston Scientific have been focusing on enhancing their product offerings to include advanced balloon technologies that improve patient outcomes.

Notably, in September 2023, Abbott Laboratories announced the launch of a new line of drug-eluting balloons, aimed at providing more effective treatment options for patients suffering from coronary artery disease.

Furthermore, a strategic merger was confirmed in August 2023, where Philips Healthcare acquired a small biotechnology firm specializing in innovative angioplasty balloon technologies, thereby augmenting its portfolio.

Meanwhile, Asahi Intecc reported a steady growth in market valuation due to the increasing adoption of minimally invasive procedures, reflecting a broader industry trend aligning with healthcare advancements.

In recent years, significant investments led by Johnson and Johnson and Cook Medical into Research and Development activities have aimed to drive innovation in angioplasty balloon designs, contributing to the overall market growth.

These advancements and corporate strategies highlight the evolving landscape of the Angioplasty Balloons Market as companies look to capture market share through technological improvements and strategic collaborations.

Future Outlook

Angioplasty Balloons Market Future Outlook

The Angioplasty Balloons Market is projected to grow at a 3.81% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

New opportunities lie in:

Development of biodegradable angioplasty balloons for enhanced patient safety.
Expansion into emerging markets with tailored product offerings.
Integration of smart technology for real-time monitoring during procedures.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

Angioplasty Balloons Market Type Outlook

Drug-Eluting Balloons
Plain Old Balloons
Scoring Balloons

Angioplasty Balloons Market End Use Outlook

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

Angioplasty Balloons Market Material Outlook

Polymer
Latex
Metal

Angioplasty Balloons Market Application Outlook

Coronary Angioplasty
Peripheral Angioplasty
Renal Angioplasty

Report Scope

MARKET SIZE 2024	3.38(USD Billion)
MARKET SIZE 2025	3.509(USD Billion)
MARKET SIZE 2035	5.1(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	3.81% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Advancements in biodegradable materials enhance safety and efficacy in the Angioplasty Balloons Market.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the angioplasty balloons market.
Countries Covered	North America, Europe, APAC, South America, MEA